Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase 2a Pilot, Open Label, Multicenter, Study of INV-102 Ophthalmic Solution in Subjects With Diabetic Macular Edema (DME) Associated With Non-proliferative Diabetic Retinopathy (NPDR)

Next Previous
Trial Profile

Phase 2a Pilot, Open Label, Multicenter, Study of INV-102 Ophthalmic Solution in Subjects With Diabetic Macular Edema (DME) Associated With Non-proliferative Diabetic Retinopathy (NPDR)

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 04 Feb 2026

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs INV-102-Invirsa (Primary)
  • Indications Diabetic retinopathy
  • Focus Therapeutic Use
  • Sponsors Invirsa

Most Recent Events

  • 27 Jan 2026 Status changed from recruiting to completed.
  • 07 Mar 2025 Number of treatment arms are increased from 1 to 2 by the addition of Experimental: Part 2: INV-102 0.7% in Center-involved Diabetic Macular Edema (CIDME) arm. Inclusion criteria is also expanded to include both kinds of subjects having NCIDME (in Part 1) or CIDME (in Part 2).
  • 03 Dec 2024 Planned End Date changed from 1 Mar 2025 to 1 Aug 2025.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top